- Home
- CYCN vs SSY Comparison
CYCN vs SSY Comparison
Compare CYCN & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- SSY
- Stock Information
- Founded
- CYCN 2018
- SSY 1959
- Country
- CYCN United States
- SSY United States
- Employees
- CYCN N/A
- SSY N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- SSY Hospital/Nursing Management
- Sector
- CYCN Health Care
- SSY Health Care
- Exchange
- CYCN Nasdaq
- SSY Nasdaq
- Market Cap
- CYCN 6.5M
- SSY 6.3M
- IPO Year
- CYCN N/A
- SSY N/A
- Fundamental
- Price
- CYCN $3.01
- SSY $0.88
- Analyst Decision
- CYCN
- SSY
- Analyst Count
- CYCN 0
- SSY 0
- Target Price
- CYCN N/A
- SSY N/A
- AVG Volume (30 Days)
- CYCN 12.7K
- SSY 13.1K
- Earning Date
- CYCN 05-06-2025
- SSY 05-14-2025
- Dividend Yield
- CYCN N/A
- SSY N/A
- EPS Growth
- CYCN N/A
- SSY N/A
- EPS
- CYCN N/A
- SSY 0.14
- Revenue
- CYCN $2,000,000.00
- SSY $31,233,000.00
- Revenue This Year
- CYCN N/A
- SSY N/A
- Revenue Next Year
- CYCN N/A
- SSY N/A
- P/E Ratio
- CYCN N/A
- SSY $6.05
- Revenue Growth
- CYCN N/A
- SSY N/A
- 52 Week Low
- CYCN $1.27
- SSY $0.53
- 52 Week High
- CYCN $9.47
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- CYCN 61.70
- SSY 44.82
- Support Level
- CYCN $2.44
- SSY $0.85
- Resistance Level
- CYCN $2.75
- SSY $0.98
- Average True Range (ATR)
- CYCN 0.19
- SSY 0.10
- MACD
- CYCN 0.06
- SSY -0.00
- Stochastic Oscillator
- CYCN 95.31
- SSY 61.54
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.